Tools for Health and Resilience Implemented After Violence Exposure (Project THRIVE)

Sponsor
University of Washington (Other)
Overall Status
Recruiting
CT.gov ID
NCT03703258
Collaborator
National Institute on Alcohol Abuse and Alcoholism (NIAAA) (NIH)
40
1
2
31.5
1.3

Study Details

Study Description

Brief Summary

Sexual assault victimization is a common and particularly harmful form of trauma that is associated with increased risk for high-risk drinking and other conditions of public health concern, such as PTSD. Given evidence that sexual assault survivors who have low social support or receive negative social reactions to sexual assault disclosure are more likely to experience PTSD and drinking problems, improving social support is a novel target for intervention. The proposed study will attempt to prevent the onset of high-risk drinking and PTSD in sexual assault survivors by developing and testing a web-based early intervention aimed at increasing contact with social supporters and mitigating the harm of negative social reactions; ultimately, results will contribute to advancing the field's understanding of the potential for social support to mitigate the harm of trauma.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: App-based intervention
N/A

Detailed Description

This study involves developing, modifying, and preliminarily testing an intervention to prevent high-risk drinking and PTSD in women who have experienced sexual assault (SA) in the past 10 weeks. In the pilot trial phase of this study, intervention feasibility will be tested in an open trial with N = 40 women with past-10-week SA histories, active drinking, and elevated distress. Participants will complete surveys at baseline, termination, and 3-month follow-up. Participants will be randomized to either the intervention (N = 20) or assessment-only control (N = 20). We hypothesize that (H1) most participants will respond positively on items assessing satisfaction with the intervention, (H2) participants will report above-average usability on a standardized measure, (H3) completion rates for daily activities will be similar to previous web-based interventions, (H4) participants will show significant learning as evidenced by increases in correct responses to knowledge questions from baseline to post, and (H5) participants in the intervention condition will evidence less high-risk drinking and PTSD at 3-month follow-up than participants in the assessment-only condition.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Preventing Risky Drinking and PTSD After Sexual Assault: A Web-Based Intervention
Actual Study Start Date :
Jan 14, 2021
Anticipated Primary Completion Date :
Mar 1, 2023
Anticipated Study Completion Date :
Sep 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

The THRIVE app involves 3 weeks of daily activities. Day 1 involves identification of activities to add to a "self-care activity list" with guidance around selecting activities that increase social contact, reduce alcohol use, and reduce avoidance. They will also complete an active-learning exercise about cognitive distortions and create a "stuck point to-do list" consisting of their cognitive distortions. In subsequent days, participants will be prompted to complete activities from both lists. They will also have access optional activities on topics such as asking for help, preventing isolation, deciding whether to disclose an assault, coping with negative reactions to disclosure, and thinking in helpful ways about social support. They will be prompted to complete brief daily surveys in the app, which will populate a symptom tracker. Participants in will have brief weekly phone contact with a coach to monitor safety and troubleshoot issues with app use.

Behavioral: App-based intervention
A app-based cognitive-behavioral intervention to prevent the development of PTSD and high-risk drinking in recently-victimized adults
Other Names:
  • THRIVE app
  • No Intervention: Assessment-only control

    The assessment-only control condition will involve access to a version of the app that includes daily surveys and a symptom tracker populated by these surveys, but without any of the other exercises included in the experimental version of the app. Participants in the control condition will have brief weekly phone contact with a coach to monitor safety and troubleshoot issues with app use.

    Outcome Measures

    Primary Outcome Measures

    1. Change in problem drinking at 3 weeks [Baseline, post-intervention (3 weeks after baseline)]

      Sum scores on Rutgers Alcohol Problem Index- Short Form (RAPI-S). Range: 0-64; higher scores indicate worse outcome.

    2. Change in problem drinking at 3 months [Baseline, 3 month follow-up]

      Sum scores on Rutgers Alcohol Problem Index- Short Form (RAPI-S). Range: 0-64; higher scores indicate worse outcome.

    3. Change in posttraumatic stress symptoms at 3 weeks [Baseline, post-intervention (3 weeks after baseline)]

      Sum scores on PTSD Checklist-5 (PCL-5). Range: 0-80; higher scores indicate worse outcome.

    4. Change in posttraumatic stress symptoms at 3 months [Baseline, 3 month follow-up]

      Sum scores on PTSD Checklist-5 (PCL-5). Range: 0-80; higher scores indicate worse outcome.

    Secondary Outcome Measures

    1. Anxiety [Baseline, post-intervention (3 weeks after baseline), 3 month follow-up]

      Sum scores on GAD-7. Range: 0-21; higher scores indicate worse outcome.

    2. Coping self-efficacy [Baseline, post-intervention (3 weeks after baseline), 3 month follow-up]

      Mean scores on the Trauma Coping Self-Efficacy Scale (CSE-T). Range: 1 to 7; higher scores indicate better outcome.

    3. Depression [Baseline, post-intervention (3 weeks after baseline), 3 month follow-up]

      Sum scores on the PHQ-8. Range: 0-24; higher scores indicate worse outcome.

    4. Alcohol consumption (quantity) [Baseline, post-intervention (3 weeks after baseline), 3 month follow-up]

      Number of drinks per week reported on the Daily Drinking Questionnaire

    5. Alcohol consumption (frequency) [Baseline, post-intervention (3 weeks after baseline), 3 month follow-up]

      Number of drinking days per week reported on the Daily Drinking Questionnaire

    6. Alcohol consumption (hours) [Baseline, post-intervention (3 weeks after baseline), 3 month follow-up]

      Hours spent drinking per week reported on the Daily Drinking Questionnaire

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • informed consent

    • self-identification as female

    • sexual assault, defined as endorsement of unwanted, attempted or completed sexual contact in the past 10 weeks

    • age > 18

    • English fluency

    • smartphone and internet access at least daily for 3 weeks and at least weekly for 3 months

    • consumption of >1 alcoholic drink in the past month

    • 1 episode of high-risk drinking in past 6 months, defined as either more than 3 drinks on a given day or more than 7 drinks in a given week

    • at least 3 symptom clusters endorsed on the PTSD Checklist.

    Exclusion Criteria:
    • active suicidality

    • psychosis

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Washington School of Medicine Seattle Washington United States 98105

    Sponsors and Collaborators

    • University of Washington
    • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    Investigators

    • Principal Investigator: Emily Dworkin, PhD, University of Washington

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Emily Dworkin, Acting Assistant Professor, School of Medicine: Psychiatry, University of Washington
    ClinicalTrials.gov Identifier:
    NCT03703258
    Other Study ID Numbers:
    • STUDY00005025
    • R00AA026317
    First Posted:
    Oct 11, 2018
    Last Update Posted:
    Jul 13, 2021
    Last Verified:
    Jul 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 13, 2021